Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Varga

Showing results (31-40 of 297) with videos related to

Pageof 30
Sort By:
Nature Reviews. Rheumatology|January 13, 2017
Systemic sclerosis in 2016: Dermal white adipose tissue implicated in SSc pathogenesisJohn Varga, Roberta G Marangoni
Arthritis Research & Therapy|August 26, 2010
Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and managementFlavia V Castelino, John Varga
Nature Reviews. Rheumatology|November 7, 2025
Cell-free DNA fragmentation signatures link cancer and autoimmunityLam C Tsoi, John Varga
Trends in Immunology|September 20, 2005
Scleroderma: from cell and molecular mechanisms to disease modelsDavid J Abraham, John Varga
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|September 21, 2020
Scleroderma Renal Crisis Complicating Male-to-Female Transgender Hormonal Therapy in a Patient With Long-Standing and Stable Limited Cutaneous Systemic SclerosisLaura C Arneson, John Varga
Annals of the Rheumatic Diseases|October 17, 2019
Getting to the heart of the matter: detecting and managing cardiac complications in systemic sclerosisJohn Varga, Daniel C Lee
Nature Reviews. Rheumatology|February 24, 2019
Emerging targets of disease-modifying therapy for systemic sclerosisElizabeth R Volkmann, John Varga
Journal of Cellular Physiology|June 15, 2007
The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosisAsish K Ghosh, John Varga
The Journal of Investigative Dermatology|October 23, 2017
Early-Life Gut Dysbiosis: A Driver of Later-Life Fibrosis?Karen J Ho, John Varga
Expert Review of Clinical Immunology|October 31, 2013
Current status of systemic sclerosis biomarkers: applications for diagnosis, management and drug developmentFlavia V Castelino, John Varga
Pageof 30

Showing results (31-40 of 297) with videos related to

Sort By:
Pageof 30
Nature Reviews. Rheumatology|January 13, 2017
Systemic sclerosis in 2016: Dermal white adipose tissue implicated in SSc pathogenesisJohn Varga, Roberta G Marangoni
Arthritis Research & Therapy|August 26, 2010
Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and managementFlavia V Castelino, John Varga
Nature Reviews. Rheumatology|November 7, 2025
Cell-free DNA fragmentation signatures link cancer and autoimmunityLam C Tsoi, John Varga
Trends in Immunology|September 20, 2005
Scleroderma: from cell and molecular mechanisms to disease modelsDavid J Abraham, John Varga
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|September 21, 2020
Scleroderma Renal Crisis Complicating Male-to-Female Transgender Hormonal Therapy in a Patient With Long-Standing and Stable Limited Cutaneous Systemic SclerosisLaura C Arneson, John Varga
Annals of the Rheumatic Diseases|October 17, 2019
Getting to the heart of the matter: detecting and managing cardiac complications in systemic sclerosisJohn Varga, Daniel C Lee
Nature Reviews. Rheumatology|February 24, 2019
Emerging targets of disease-modifying therapy for systemic sclerosisElizabeth R Volkmann, John Varga
Journal of Cellular Physiology|June 15, 2007
The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosisAsish K Ghosh, John Varga
The Journal of Investigative Dermatology|October 23, 2017
Early-Life Gut Dysbiosis: A Driver of Later-Life Fibrosis?Karen J Ho, John Varga
Expert Review of Clinical Immunology|October 31, 2013
Current status of systemic sclerosis biomarkers: applications for diagnosis, management and drug developmentFlavia V Castelino, John Varga
Pageof 30